欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

不尽人意的选择性血清素再吸收抑制剂治疗抑郁症

Treatment for Depression After Unsatisfactory Response to SSRIs
加工时间:2014-09-19 信息来源:科技报告(PB) 索取原文[16 页]
关键词:临床治疗;抑郁;搜索策略;患者;治疗反应;数据提取
摘 要:Depression is a complex mental illness associated with disability and reduced quality of life for the person with depression, as well as substantial societal burden. Major depressive disorder (MDD) is the second leading medical cause of long-term disability, the fourth leading cause of global burden of disease, and is predicted to become the second highest cause of disability by 2020. Depression exerts a negative impact on physical health; it reduces adherence to medical treatment, reduces participation in preventive activities, and increases the likelihood of risk factors such as obesity, smoking, and sedentary lifestyles. MDD may be associated with immune dysfunction and cardiovascular disease, endocrine and neurological diseases, and a general increase in chronic disease incidence. The primary goal of this comparative effectiveness review is to examine the evidence guiding clinical treatment decisions and ultimately to aid clinicians in their care of patients when selective serotonin reuptake inhibitors (SSRIs) therapy for an index episode does not result in an adequate treatment response.
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服